Immuron Limited
IMRN
$2.35
$0.146.34%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 47.00% | 62.05% | 82.60% | 111.54% | 164.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.00% | 62.05% | 82.60% | 111.54% | 164.32% |
| Cost of Revenue | 59.17% | 105.96% | 215.64% | 401.52% | 2,293.94% |
| Gross Profit | 41.29% | 46.27% | 51.74% | 65.81% | 86.47% |
| SG&A Expenses | 18.82% | 28.53% | 39.79% | 33.36% | 24.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 59.18% | 40.06% | 16.91% | -5.64% | -28.18% |
| Total Operating Expenses | 23.38% | 43.34% | 71.40% | 80.15% | 89.10% |
| Operating Income | -1.19% | -25.29% | -60.19% | -55.93% | -49.21% |
| Income Before Tax | 25.96% | -15.32% | -88.13% | -84.67% | -78.76% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 25.96% | -15.32% | -88.13% | -84.67% | -78.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 25.96% | -15.32% | -88.13% | -84.67% | -78.76% |
| EBIT | -1.19% | -25.29% | -60.19% | -55.93% | -49.21% |
| EBITDA | -1.22% | -25.52% | -60.48% | -56.15% | -49.36% |
| EPS Basic | 27.50% | -13.38% | -85.09% | -82.30% | -76.99% |
| Normalized Basic EPS | 21.55% | -20.22% | -98.39% | -96.72% | -90.16% |
| EPS Diluted | 26.50% | -14.65% | -86.84% | -83.19% | -76.99% |
| Normalized Diluted EPS | 21.55% | -20.22% | -98.39% | -96.72% | -90.16% |
| Average Basic Shares Outstanding | 1.35% | 0.77% | 0.19% | 0.11% | 0.03% |
| Average Diluted Shares Outstanding | 1.35% | 0.77% | 0.19% | 0.11% | 0.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |